Abstract
Objective: About 10% of epithelial ovarian cancers arise in women with mutations in high penetrance genes (BRCA1/2), but these account for only about 40% of excess familial risk. The Ovarian Cancer Association Consortium (OCAC) has previously found 6 common single nucleotide polymorphisms (SNPs) using genome wide association studies (GWAS) that increase overall and serous ovarian cancer risk, but these only account for an additional 4% of familial risk. The Collaborative Oncological Gene-Environment Study (COGS), an ovarian, breast and prostate cancer consortium, sought to validate additional risk SNPs at a genome wide level of significance.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
